Bionik Laboratories BNKL Stock
Bionik Laboratories Price Chart
Bionik Laboratories BNKL Financial and Trading Overview
Bionik Laboratories stock price | 0.0001 USD |
Previous Close | 0.64 USD |
Open | 0.54 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.54 - 0.54 USD |
52 Week Range | 0.25 - 2.9 USD |
Volume | 1.11K USD |
Avg. Volume | 3.05K USD |
Market Cap | 3.71M USD |
Beta (5Y Monthly) | -1.229225 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.72 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BNKL Valuation Measures
Enterprise Value | 5.65M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.4838371 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 3.779 |
Enterprise Value/EBITDA | -1.16 |
Trading Information
Bionik Laboratories Stock Price History
Beta (5Y Monthly) | -1.229225 |
52-Week Change | -45.99% |
S&P500 52-Week Change | 20.43% |
52 Week High | 2.9 USD |
52 Week Low | 0.25 USD |
50-Day Moving Average | 0.47 USD |
200-Day Moving Average | 0.47 USD |
BNKL Share Statistics
Avg. Volume (3 month) | 3.05K USD |
Avg. Daily Volume (10-Days) | 18.07K USD |
Shares Outstanding | 6.88M |
Float | 3.22M |
Short Ratio | N/A |
% Held by Insiders | 61.64% |
% Held by Institutions | 1.18% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:150 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | March 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -329.63% |
Gross Margin | 58.07% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -63.74% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 1.5M USD |
Revenue Per Share (ttm) | 0.23 USD |
Quarterly Revenue Growth (yoy) | 213.79% |
Gross Profit (ttm) | 953.26K USD |
EBITDA | -4872712 USD |
Net Income Avi to Common (ttm) | -5294980 USD |
Diluted EPS (ttm) | -1.02 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 685.2K USD |
Total Cash Per Share (mrq) | 0.1 USD |
Total Debt (mrq) | 1.86M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 1.47 |
Book Value Per Share (mrq) | -0.076 |
Cash Flow Statement
Operating Cash Flow (ttm) | -4010251 USD |
Levered Free Cash Flow (ttm) | -2178075 USD |
Profile of Bionik Laboratories
Country | United States |
State | MA |
City | Watertown |
Address | 80 Coolidge Hill Road |
ZIP | 02472 |
Phone | 617 926 4800 |
Website | https://www.bioniklabs.com |
Industry | Medical Care Facilities |
Sector(s) | Healthcare |
Full Time Employees | 12 |
Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.
Q&A For Bionik Laboratories Stock
What is a current BNKL stock price?
Bionik Laboratories BNKL stock price today per share is 0.0001 USD.
How to purchase Bionik Laboratories stock?
You can buy BNKL shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bionik Laboratories?
The stock symbol or ticker of Bionik Laboratories is BNKL.
Which industry does the Bionik Laboratories company belong to?
The Bionik Laboratories industry is Medical Care Facilities.
How many shares does Bionik Laboratories have in circulation?
The max supply of Bionik Laboratories shares is 12.48M.
What is Bionik Laboratories Price to Earnings Ratio (PE Ratio)?
Bionik Laboratories PE Ratio is now.
What was Bionik Laboratories earnings per share over the trailing 12 months (TTM)?
Bionik Laboratories EPS is -0.72 USD over the trailing 12 months.
Which sector does the Bionik Laboratories company belong to?
The Bionik Laboratories sector is Healthcare.